Jorge Camarero

Jorge Camarero, Ph.D., has more than 15 years’ experience within the EU regulatory system, primarily in oncology and advanced therapies, along with small molecules, monoclonal antibodies, biosimilars and other protein products. Dr. Camarero is also experienced in the provision of National and EU Scientific Advice.

His experience in academia and the EMA allow for the provision of sound scientific and regulatory advice on clinical drug development and submission strategies.

Work experience

Jorge served at the European Medicines Agency (EMA) in The Netherlands as an alternate member of the Committee for Medicinal Products for Human Use (CHMP) and as a member the Oncology Working Party. Prior to his tenure at the EMA, he was Head of the Oncology Area for the Spanish Agency for Medicines and Medical Devices (AEMPS); a Pharmaceutical Inspector for the Spanish Government’s Health Department delegation; and a Regulatory Clinical Assessor in Oncology for Spanish Agency for the AEMPS.

Prior to this, he was Pre-doctoral and Post-doctoral researcher in Pharmacology Department of the Medicine School

Education

Jorge has a PhD degree in Pharmacology from the Complutense University of Madrid, a Master in Assessment and Market Access in the Pharmaceutical Sector from Carlos III University and Master in Science (Research and Development of new medicines) from the Navarra University.

He has published nearly two dozen scholarly articles in the fields of oncology, pharmacology, neurochemistry and immunotherapeutics.